Tenax Therapeutics

NEWS

Business

BioSpace Movers & Shakers, Feb. 4

Biopharma and life sciences companies strengthen their boards and leadership teams with these Movers & Shakers.

February 3, 2022

9 min read

Alex Keown

Business

New CEOs Named at Two Biopharma Companies

Scorpion Therapeutics announced its new CEO Dr. Axel Hoos while Tenax Therapeutics named Christopher Giordano as its new chief executive.

July 8, 2021

2 min read

Vanessa Doctor, RN

IN THE PRESS

Drug Development

Tenax Therapeutics Announces Last Patient Completes Final Visit in its Phase 2 “HELP Study” of Levosimendan for Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction

April 9, 2020

5 min read

Drug Development

Tenax Therapeutics Completes Enrollment in Phase 2 Pulmonary Hypertension Trial

March 12, 2020

5 min read

Business

Tenax Therapeutics Announces $2.75 Million Registered Direct Offering Priced At-the-Market

March 12, 2020

5 min read

Business

Tenax Announces the Addition of Mayo Clinic Expert, Dr. Barry Borlaug, to Scientific Advisory Board

February 21, 2020

4 min read

Drug Development

Tenax Therapeutics Provides Update on Phase 2 Pulmonary Hypertension Clinical Trial

October 31, 2019

4 min read

Bio NC

Tenax Therapeutics to Present at H.C. Wainwright 21st Annual Global Investment Conference

August 29, 2019

3 min read

Bio NC

Tenax Therapeutics Provides Clinical Development Update

August 23, 2019

4 min read

Bio NC

Tenax Therapeutics to Present at 2019 BIO CEO & Investor Conference

February 4, 2019

2 min read

Bio NC

Tenax Therapeutics to Present at Biotech Showcase Investor Conference

January 4, 2019

3 min read

Bio NC

Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering

December 11, 2018

4 min read

JOBS